Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl (Q34423200)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl |
scientific article |
Statements
1 reference
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl (English)
1 reference
David G Warnock
1 reference
Nosratola D Vaziri
1 reference
Melanie P Chin
1 reference
Scott A Reisman
1 reference
George L Bakris
1 reference
Megan O'Grady
1 reference
Peter G Linde
1 reference
Peter A McCullough
1 reference
David Packham
1 reference
Keith W Ward
1 reference
Colin J Meyer
1 reference
1 reference
Identifiers
1 reference